Searched for
REMOGLIFLOZIN ETABONATE
For investors looking beyond the short-term horizon: 5 mid-cap stocks from different sectors with upside potential up to 28%- These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analysts
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...12 Jun, 2026, 12.25 PM IST
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...23 May, 2026, 10.24 PM IST
- Will the currency cycle help them? Yes, but very selectively: 10 pharma stocks with upside potential of up to 33%The biggest mistake made in currency cycles is to confuse revenue gain with pure earnings gain. A company may report stronger rupee revenue...28 Mar, 2026, 12.24 PM IST
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 41%The bears seem to have friends on the street who come to their rescue out of nowhere. For instance, the sudden developments in the AI space...13 Feb, 2026, 10.24 PM IST
- Stock picks of the week: Stocks with consistent score improvement and return potential of more than 36% in 1 yearThe way the Nifty and Sensex moved on Friday will make many think of volatility again. But it could have been just profit-booking after a s...24 Oct, 2025, 10.20 PM IST
- Pharma stocks: With headwinds of uncertainty over, will they outperform? 7 stocks with an upside potential of up to 43%When it is Trump, logic usually flies out of the window. There is, indeed, little that is logical about the reciprocal tariffs he has annou...03 Apr, 2025, 06.56 PM IST
- Stock picks of the week: 5 stocks with consistent score improvement and an upside potential of up to 36%The volatility quotient has been high for the last couple of weeks. But with the Q3 earning season winding down, things may cool down a bit...17 Feb, 2025, 02.18 PM IST
- Stock picks of the week: 5 stocks with consistent score improvement and an upside potential of up to 48%Once again the global markets have been hit by Trump’s tariff tantrums. Now, let’s leave aside the global development, which was partly exp...03 Feb, 2025, 01.47 PM IST
- Delhi High Court seeks response from govt, NPPA on Glenmark's pleaDelhi High Court hears Glenmark Pharma's petition against NPPA's pricing order for anti-diabetic drugs, claiming arbitrary pricing and seek...09 Apr, 2024, 07.31 PM IST
- On a path to recovery; 7 mid-cap pharma stocks with an upside potential up to 47 %After the covid tailwinds got over, pharma stocks witnessed a phase of under-performance. However as the markets get jittery, select pharma...02 Mar, 2023, 01.04 PM IST
- Weekly Top Picks: 5 stocks with an upside potential of up to 39%Budget 2023, RBI policy and events around Adani group ensured that Nifty stays in volatile mode with bearish bias. However, even during thi...11 Feb, 2023, 11.40 AM IST
- These 5 midcap stocks with ‘strong buy’ & ‘buy’ ratings can rally over 25%, say analystsFor all those who are busy guessing what will happen to Adani group stocks, there is a market beyond Adani stocks and that is very large. E...09 Feb, 2023, 05.56 PM IST
- Defensive Bets: 4 midcaps from pharma sector with ‘Buy’ & ‘Strong Buy’ ratings have upside potential of up to 31%As NIFTY gets even more volatile, there are some sectors which are traditionally considered defensive and they tend to get attention when m...07 Feb, 2023, 02.46 PM IST
- 7 midcap stocks, 1 with “Strong Buy” and 6 with “Buy” recommendations with potential upside of up to 30%Four pharma companies, a southern india focussed real estate player to mid-cap software company have seen an improvement in their overall s...27 Dec, 2022, 11.28 AM IST
- Glenmark launches unique fixed dose combination drug for diabetesThe Mumbai based drug firm said it has introduced fixed dose combination (FDC) of its novel, patent protected Sodium Glucose Co-Transporter...26 Oct, 2021, 11.47 AM IST
- Violation of drug price control order: Drug cos under NPPA lens for self-exemption from price capPricing watchdog has found that companies such as Lupin and Boehringer Ingelheim launched products bypassing the regulatory framework. The ...16 Dec, 2019, 08.31 PM IST
- Glenmark Pharma launches anti-diabetes drug Remogliflozin in IndiaGlenmark said it will commercialise Remogliflozin in India under the brand names 'Remo' and 'Remozen'.30 Apr, 2019, 12.20 PM IST
Load More
